Celltrion | 068270 - Net Income

Stock Price
193,700.00
Daily Change
-2,100.00 -1.07%
Monthly
-5.05%
Yearly
18.76%
Q2 Forecast
184,597.56

Celltrion reported KRW331.35B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025